Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity Post author: Post published:February 15, 2024 Post category:uncategorized Researchers evaluated rational combination treatment regimens for advanced/metastatic non-small-cell lung cancer (NSCLC). You Might Also Like Lab-grown organoid offers a platform to study how liver scarring develops October 31, 2025 Healthy eating may come at the expense of exploited workers October 9, 2025 How preschool in Japan shaped teen choices decades later April 9, 2025